268 related articles for article (PubMed ID: 18554281)
1. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
[TBL] [Abstract][Full Text] [Related]
2. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
Barrow E; Robinson L; Alduaij W; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
Clin Genet; 2009 Feb; 75(2):141-9. PubMed ID: 19215248
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
4. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
5. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
6. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
7. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
Möslein G
Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
[TBL] [Abstract][Full Text] [Related]
9. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
10. Estimating cancer risk in HNPCC by the GRL method.
Alarcon F; Lasset C; Carayol J; Bonadona V; Perdry H; Desseigne F; Wang Q; Bonaïti-Pellié C
Eur J Hum Genet; 2007 Aug; 15(8):831-6. PubMed ID: 17473834
[TBL] [Abstract][Full Text] [Related]
11. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
13. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.
Diergaarde B; Braam H; Vasen HF; Nagengast FM; van Muijen GN; Kok FJ; Kampman E
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):736-42. PubMed ID: 17544999
[TBL] [Abstract][Full Text] [Related]
14. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset.
Jones JS; Amos CI; Pande M; Gu X; Chen J; Campos IM; Wei Q; Rodriguez-Bigas M; Lynch PM; Frazier ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):886-91. PubMed ID: 16702365
[TBL] [Abstract][Full Text] [Related]
15. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Scand J Gastroenterol; 2007 May; 42(5):628-32. PubMed ID: 17454884
[TBL] [Abstract][Full Text] [Related]
17. [Hereditary colorectal cancer].
Bernstein IT; Bülow S
Ugeskr Laeger; 2005 Oct; 167(44):4159-63. PubMed ID: 16266567
[TBL] [Abstract][Full Text] [Related]
18. [Families at risk of colon cancer II. Hereditary nonpolyposis colorectal carcinoma].
Hlavatý T; Lukác L; Duris I
Vnitr Lek; 2004 Aug; 50(8):606-14. PubMed ID: 15521204
[TBL] [Abstract][Full Text] [Related]
19. Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).
Ramsoekh D; Van Leerdam ME; Wagner A; Kuipers EJ
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():101-11. PubMed ID: 18081654
[TBL] [Abstract][Full Text] [Related]
20. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
